Lorenzo Tallarigo, Director, 10% Owner at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 1,839 shares at $67.41 ($124K) on 2014-01-07, disclosed to the SEC on 2014-01-09.
Scheduled sale ($124k) by Director, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ICPT | SELL | 2014-04-11 | $111.0M | — | Filing → |
| ICPT | SELL | 2014-02-11 | $130K | — | Filing → |
| ICPT | SELL | 2013-10-23 | $7.8M | — | Filing → |